Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ida Landini

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 30, 2011
Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategiesFrancesco Crea, Stefania Nobili, Elisa Paolicchi, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2005
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part IRosaria Ottanà, Stefania Carotti, Rosanna Maccari, et al.
Scientific Reports|March 7, 2025
Effects of reduced extracellular sodium on proliferation and invasive activity of renal cell carcinoma cell linesLaura Naldi, Martina Catalano, Maria Elena Melica, et al.
World Journal of Gastroenterology|January 22, 2011
Genomic and genetic alterations influence the progression of gastric cancerStefania Nobili, Lorenzo Bruno, Ida Landini, et al.
Oncology Research|March 9, 2018
ERRATUMEnrico Mini, Ida Landini, Laura Lucarini, et al.
Oncotarget|December 10, 2017
Selection and characterization of a human ovarian cancer cell line resistant to auranofinIda Landini, Andrea Lapucci, Alessandro Pratesi, et al.
International Journal of Cancer|June 19, 2010
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancerStefania Nobili, Cristina Napoli, Ida Landini, et al.
Oncology Research|April 22, 2017
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response PathwaysEnrico Mini, Ida Landini, Laura Lucarini, et al.
Free Radical Biology & Medicine|February 2, 2016
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathyLorenzo Di Cesare Mannelli, Matteo Zanardelli, Ida Landini, et al.
Journal of Inorganic Biochemistry|March 23, 2011
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligandLaura Maiore, Maria Agostina Cinellu, Elena Michelucci, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|September 30, 2011
Epigenetics and chemoresistance in colorectal cancer: an opportunity for treatment tailoring and novel therapeutic strategiesFrancesco Crea, Stefania Nobili, Elisa Paolicchi, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2005
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part IRosaria Ottanà, Stefania Carotti, Rosanna Maccari, et al.
Scientific Reports|March 7, 2025
Effects of reduced extracellular sodium on proliferation and invasive activity of renal cell carcinoma cell linesLaura Naldi, Martina Catalano, Maria Elena Melica, et al.
World Journal of Gastroenterology|January 22, 2011
Genomic and genetic alterations influence the progression of gastric cancerStefania Nobili, Lorenzo Bruno, Ida Landini, et al.
Oncology Research|March 9, 2018
ERRATUMEnrico Mini, Ida Landini, Laura Lucarini, et al.
Oncotarget|December 10, 2017
Selection and characterization of a human ovarian cancer cell line resistant to auranofinIda Landini, Andrea Lapucci, Alessandro Pratesi, et al.
International Journal of Cancer|June 19, 2010
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancerStefania Nobili, Cristina Napoli, Ida Landini, et al.
Oncology Research|April 22, 2017
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response PathwaysEnrico Mini, Ida Landini, Laura Lucarini, et al.
Free Radical Biology & Medicine|February 2, 2016
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathyLorenzo Di Cesare Mannelli, Matteo Zanardelli, Ida Landini, et al.
Journal of Inorganic Biochemistry|March 23, 2011
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligandLaura Maiore, Maria Agostina Cinellu, Elena Michelucci, et al.
Pageof 5